this post was submitted on 04 Nov 2025
25 points (100.0% liked)

Medicine Canada

315 readers
1 users here now

A community for Canadian physicians and medical professionals


🍁 While this community is intended for Canadian discussions, you are free to post about other medical systems. We're all in this together :)



Related Communities

For better links and descriptions, see the pinned post in the Medical Community Hub (!medicine@lemmy.world)


Rules

  1. No requests for professional advice or general medical information. Please do not solicit medical advice or share personal health anecdotes about yourself or others.

  2. No promotions, advertisements, surveys, or petitions.

  3. Link to high-quality, original research whenever possible: Posts which rely on or reference scientific data (e.g. an announcement about a medical breakthrough) should link to the original research in peer-reviewed medical journals or respectable news sources as judged by the moderators. Sensationalized titles, misrepresentation of results, or promotion of blatantly bad science may lead to removal.

  4. Act professionally and decently: /r/medicine is a public forum that represents the medical community and comments should reflect this. Please keep disagreement civil and focused on issues.

  5. Protect patient confidentiality. Please anonymize cases and remove any patient-identifiable information.

  6. No memes or low-effort posts: Memes, image links (including social media screenshots), images of text, or other low-effort posts or comments are not allowed.

These rules have been modelled after /r/medicine. While some rules were modified or skipped as this is a much smaller community, we can revisit the rules as we go. Thank you :)

founded 2 years ago
MODERATORS
 

Chemotherapy daycare nurse Karly Sidak prepares for a session at the Princess Margaret Cancer Centre in Toronto. Myeloma patients have started a campaign to call on politicians to restart pricing talks for Carvykti, a type of CAR-T therapy.

Nearly 1,000 Canadians with multiple myeloma and their caregivers have e-mailed elected officials asking that pricing talks resume for a cutting-edge immunotherapy that Health Canada approved nearly three years ago but which still isn’t available in this country.

The letter writers are pleading with the pan-Canadian Pharmaceutical Alliance, the organization that negotiates confidential discounts on drug prices on behalf of provinces and territories, to cut a deal for Carvykti, a bespoke, one-time-only infusion for the aggressive blood cancer.


From The Globe and Mail via this RSS feed

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here